
This is what you will do:
The Epidemiology and Real‑World Science team in Alexion–AstraZeneca’s Rare Disease Unit accelerates patient access to innovative medicines by advancing the scientific use of Real World Data (RWD). In this role, you will apply RWD to support the rare disease portfolio, aligned with AstraZeneca best practices and standards. Building on AstraZeneca’s strong Real World Evidence (RWE) foundation and internal data assets, the team is expanding through a dedicated Real World Data Science capability.
Successful candidates will tackle challenging problems with innovative methods to deliver Real World Insights and Evidence for stakeholders in Clinical Development, Regulatory, and Patient Safety. The ideal candidate is a curious, self‑directed learner with a proven record of deriving value from routinely collected healthcare or observational data, delivering health analytics across Public Health, Pharmaceutical R&D, Commercial/Payer, and Patient Safety.
You will provide methods expertise, lead and support analyses of RWD, and guide study design, data source selection, and best practices in RWD utilization, emphasizing patient safety. You will also help shape Alexion/AZ’s RWS data strategy by supporting due diligence on data vendors and offering informatics support for Therapeutic Area data acquisitions.
You will be responsible for:
You will need to have:
We would prefer for you to have:
18-Sept-2026
01-Oct-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy